AstraZeneca lost a federal appeals court ruling and must pay $13 million in damages for manipulating the price of prostate cancer drug Zoladex. The case involved an AZ campaign to persuade doctors to ...

Does higher number of lymph nodes (LNs) excised during radical prostatectomy (RP) improve biochemical relapse-free survival (bRFS) in patients with pT2-3a/pN0 prostate cancer? This is an ASCO Meeting ...

October 14, 2009 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to warn of the risk for leukopenia/neutropenia in patients receiving antipsychotics, including ...

Goserelin (as acetate) 10.8mg; SC implant. Zoladex is a synthetic decapeptide analogue of GnRH. It acts as an inhibitor of pituitary gonadotropin secretion when administered in the biodegradable ...

PINE BROOK, N.J.--(BUSINESS WIRE)--Alvogen today announced the launch of the first generic equivalent of Zoladex TM in Central and Eastern Europe. The product will be marketed in two strengths (3.6mg ...

AstraZeneca’s oncology drug Zoladex (goserelin) extends the life of patients suffering from prostate cancer, according to the details of an independent study revealed by the Anglo-Swedish company.

DEERFIELD, Ill.--(BUSINESS WIRE)--TerSera Therapeutics LLC announced today the presentation of new real-world analyses on the treatment patterns of goserelin in women with breast cancer. The data were ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. ZOLADEX 10.8 mg contains the active ingredient goserelin acetate.

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Goserelin (Zoladex) is a synthetic analogue of ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. ZOLADEX 3.6 mg contains the active ingredient goserelin acetate.

AstraZeneca has sold the rights to its big-selling cancer drug Zoladex in Canada and the US to TerSera Therapeutics, as the UK firm moves to focus on its newer oncology products. The deal, which is ...